BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang HH, Chou JW, Liao KF, Lin ZY, Lai HC, Hsu CH, Chen CB. One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. World J Gastroenterol 2005; 11(11): 1680-1684 [PMID: 15786549 DOI: 10.3748/wjg.v11.i11.1680]
URL: https://www.wjgnet.com/1007-9327/full/v11/i11/1680.htm
Number Citing Articles
E. G. GIANNINI, C. BILARDI, P. DULBECCO, M. MAMONE, M. L. SANTI, R. TESTA, C. MANSI, V. SAVARINO. A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradicationAlimentary Pharmacology and Therapeutics 2006; 23(2): 281 doi: 10.1111/j.1365-2036.2006.02756.x
Chii-Shyan Lay, Jiun-Rong Lin. Correlation of CYP2C19 Genetic Polymorphisms With Helicobacter pylori Eradication in Patients With Cirrhosis and Peptic UlcerJournal of the Chinese Medical Association 2010; 73(4): 188 doi: 10.1016/S1726-4901(10)70039-3
Meng-Kwan Liu, I-Chen Wu, Chien-Yu Lu, Chao-Hung Kuo, Fang-Jung Yu, Chung-Jung Liu, Ping-I Hsu, Wen-Hung Hsu, Yu-Chung Su, Angela Chen, Deng-Chyang Wu, Fu-Chen Kuo, Jyh-Jou Chen. Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimensThe Kaohsiung Journal of Medical Sciences 2013; 29(7): 379 doi: 10.1016/j.kjms.2012.11.006
Ala I Sharara. Rabeprazole: the role of proton pump inhibitors inHelicobacter pylorieradicationExpert Review of Anti-infective Therapy 2005; 3(6): 863 doi: 10.1586/14787210.3.6.863
Edoardo G. Giannini, Claudio Bilardi, Pietro Dulbecco, Mario Mamone, Maria L. Santi, Roberto Testa, Carlo Mansi, Vincenzo Savarino. Can Helicobacter pylori Eradication Regimens be Shortened in Clinical Practice? An Open-label, Randomized, Pilot Study of 4 and 7-day Triple Therapy With Rabeprazole, High-dose Levofloxacin, and TinidazoleJournal of Clinical Gastroenterology 2006; 40(6): 515 doi: 10.1097/00004836-200607000-00010